Custom Antibody Development Services
Behring Campus Eystrup (BCE) is a highly experienced CRO providing comprehensive and flexible custom antibody development services to the pharma and biotech sectors. BCE has a large collection of animal models and immunisation protocols that can generate high-quality antibodies against various targets.
BCE stands out as an expert in contract research projects and immunisations tailored to meet the unique needs and specifications of its clients. Among its core offerings, BCE excels in conducting immunisation studies, a process that entails the generation of antibodies targeting specific antigens.
Custom Antibody Development Services
Benefiting from extensive animal husbandry and laboratory facilities, Behring Campus Eystrup can provide custom antibody development services. Distinguishing itself through its versatility, BCE demonstrates expertise in working with a diverse range of animal species. This includes but is not limited to mice, rabbits, llamas, alpacas, and cattle.
The company prides itself on offering fully comprehensive services, covering the entire spectrum from antigen development to the production of purified antibodies. BCE is also equipped to provide individualised work packages based on the preferences of its clients.
Highly Flexible Antibody Development Services
What sets BCE apart is its adaptability and flexibility in delivering immunisation studies and custom antibody development services. The experienced team of scientists at BCE possesses the capability to seamlessly tailor their approach to meet the exact specifications and requirements of each customer. As a CRO and research campus with extensive facilities including laboratories, animal housing, offices, and warehouses, as well as modern technologies all under one roof, BCE can offer reliable, time-efficient and cost-effective solutions, making it an ideal partner for antibody discovery, engineering, validation, and production.
This exceptional adaptability in antibody development ensures that BCE’s services align precisely with the unique needs of its clients, enhancing the overall quality and efficacy of the delivered solutions. Furthermore, subsequent preclinical testing and development can be realised together with BCE’s specialised parent company preclinics GmbH.
To learn more about how Behring Campus Eystrup can help your pharmaceutical or biotech company accelerate its R&D process and develop innovative and competitive products, please complete the Quick Contact form or email them directly at: info@behring-campus.org
